The most common adverse events in the ketamine groups were headache, cardiorespiratory issues, numbness, tingling, ...

Working with mental health advocates and Mental Health America, the “Generation Fine” project “highlights the unique ...

Patients with chronic conditions who are failing on conventional therapies may be suffering from undiagnosed major depression ...

ALTO-207 is a fixed-dose combination of pramipexole, a dopamine D3/D2 agonist with antidepressant activity demonstrated across multiple prior studies, and ondansetron, a 5-HT3 antagonist anti-emetic.

A meta-analysis of 26 trials found that IV ketamine rapidly reduced suicidal and depressive symptoms in patients with major ...

What social risk factors affecting your patients may affect their risk of major depressive disorder more than they realize?

Taking tiny, frequent amounts of the psychedelic drug lysergic acid diethylamide (LSD) might temporarily elevate mood for people diagnosed with major depressive disorder. In a small pilot study, ...

A newer brain stimulation therapy matched ECT for depression while causing less memory loss, offering a potential option for patients concerned about cognitive side effects.

Major depression fluctuates during and after pregnancy but has the highest prevalence two weeks after giving birth, a ...

Researchers discover a paradox: high cognitive performance predicts depressive relapse, contradicting traditional expectations.

This week, Mad in America examines three studies related to economic disadvantage and mental health issues. The first finds ...

In the largest mental health study of its kind, Australian researchers have found that the prevalence of major depression ...